Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
Pharmaceutical approval update.
UW-SES: A new self-efficacy scale for people with disabilities.
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis.
A phase II study of laquinimod in Crohn's disease.
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Progressive Multifocal Leukoencephalopathy
Metabolic features of the cell danger response.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial.
Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Multiple sclerosis and breast cancer.
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Epstein-Barr virus: an important vaccine target for cancer prevention.
Changes in phospholipid composition of the spinal cord in rabbits with allergic encephalomyelitis as an experimental model of multiple sclerosis.
Neuromyelitis optica.
Magnetic Resonance Imaging of Optic Neuritis in Patients With Neuromyelitis Optica Versus Multiple Sclerosis.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Pages
« first
‹ previous
…
142
143
144
145
146
147
148
149
150
…
next ›
last »